The global Stem Cell Assay market was valued at USD 536.53million in 2016 and is projected to reach USD 2858.95millionby 2025, growing at a CAGR of 20.43% from 2017 to 2025.
Stem cells have the potential to treat a wide range of diseases. The major investments in the field and scope of medical biotechnology are supposed to boost the growth of stem cell assay market during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Rising Investment in Research Related Activities
1.2 Technological Advancements
1.3 Increasing Govt. Support
1.4 Funding for Stem Cell
2. Market Restraints
2.1 Affordability of Stem Cell Therapies & Treatments
2.2 Slow Response Time of Regulatory Bodies & Training Needs
Market Segmentation:
1. By Application:
1.1 Regenerative Medicine & Therapy Development
1.1.1 Orthopedic & Musculoskeletal Spine
1.1.2 Dermatology
1.1.3 Cardiovascular
1.1.4 Central Nervous System
1.1.5 Oncology
1.1.6 Diabetes
1.1.7 Others
1.2 Drug Discovery and Development
1.3 Clinical Research
2. By Product:
2.1 Instruments
2.1.1 Micro Electrode Arrays
2.1.2 Flow Cytometer
2.1.3 Cell Imaging Systems
2.1.4 Automated Cell Counter
2.2 Detection Kits
2.2.1 ImmunoHistochemistry Kits
3. By End User:
3.1 Pharmaceutical & Biotechnology Companies
3.2 Research Institutes
3.3 Industry Research
4. By Technology:
4.1 Micro Fabricated Assisted Technology
4.1.1 Microfluidics Based Cell Trap Technologies
5. By Kits:
5.1 Adult Stem Cell Kits
5.1.1 Mesenchymal Stem Cell Kits
5.1.2 Induced Pluripotent Stem Cell Kits
5.1.3 Hematopoietic Stem Cell Kits
5.1.4 Neuronal Stem Cells Kits
5.1.5 Umbilical Cord Stem Cells
5.2 Human Embryonic Stem Cells Kits
6. By Assay:
6.1 Cell Viability & Toxicity Assays
6.2 Isolation/Purification Assays
6.3 Cell Identification Assays
6.4 Cell Proliferation Assays
6.5 Cell Differentiation Assays
6.6 Cell Function Assays
6.7 Cell Apoptosis Assays
7. By Region:
7.1 North America (U.S., Canada, Mexico)
7.2 Europe (Germany, UK, France, Rest of Europe)
7.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
7.4 Latin America (Brazil, Argentina, Rest of Latin America)
7.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. GE Healthcare
2. Promega Corporation
3. Thermo Fisher Scientific Pvt. Ltd
4. Merck Millipore
5. Cell Bio Labs, Inc.
6. Hemogenix Inc.
7. Stem Cell Technologies
8. Bio Rad
9. R&D Systems
10. Cellular Dynamics International.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Stem Cell Assaymarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL STEM CELL ASSAYMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL STEM CELL ASSAYMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL STEM CELL ASSAY MARKET, BY APPLICATION
5.1 Regenerative Medicine & Therapy Development
5.1.1 Orthopedic & Musculoskeletal Spine
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 Central Nervous System
5.1.5 Oncology
5.1.6 Diabetes
5.1.7 Others
5.2 Drug Discovery and Development
5.3 Clinical Research
6 GLOBAL STEM CELL ASSAY MARKET, BY PRODUCT
6.1 Instruments
6.1.1 Micro Electrode Arrays
6.1.2 Flow Cytometer
6.1.3 Cell Imaging Systems
6.1.4 Automated Cell Counter
6.2 Detection Kits
6.2.1 ImmunoHistochemistry Kits
7 GLOBAL STEM CELL ASSAY MARKET, BY END USER
7.1 Pharmaceutical & Biotechnology Companies
7.2 Research Institutes
7.3 Industry Research
8 GLOBAL STEM CELL ASSAY MARKET, BY TECHNOLOGY
8.1 Micro Fabricated Assisted Technology
8.1.1 Microfluidics Based Cell Trap Technologies
9 GLOBAL STEM CELL ASSAY MARKET, BY KITS
9.1 Adult Stem Cell Kits
9.1.1 Mesenchymal Stem Cell Kits
9.1.2 Induced Pluripotent Stem Cell Kits
9.1.3 Hematopoietic Stem Cell Kits
9.1.4 Neuronal Stem Cells Kits
9.1.5 Umbilical Cord Stem Cells
9.2 Human Embryonic Stem Cells Kits
10 GLOBAL STEM CELL ASSAY MARKET, BY ASSAY
10.1 Cell Viability & Toxicity Assays
10.2 Isolation/Purification Assays
10.3 Cell Identification Assays
10.4 Cell Proliferation Assays
10.5 Cell Differentiation Assays
10.6 Cell Function Assays
10.7 Cell Apoptosis Assays
11 GLOBAL STEM CELL ASSAYMARKET, BY GEOGRAPHY
11.1 Overview
11.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
11.2.1 U.S.
11.2.2 Canada
11.2.3 Mexico
11.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
11.5.1 Brazil
11.5.2 Argentina
11.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
12 GLOBAL STEM CELL ASSAYMARKETCOMPETITIVE LANDSCAPE
12.1 Overview
12.2 Company Market Share
12.3 Vendor Landscape
12.4 Key Development Strategies
13 COMPANY PROFILES
13.1 GE Healthcare
13.1.1 Overview
13.1.2 Financial Performance
13.1.3 Product Outlook
13.1.4 Key Developments
13.2 Promega Corporation
13.2.1 Overview
13.2.2 Financial Performance
13.2.3 Product Outlook
13.2.4 Key Developments
13.3 Thermo Fisher Scientific Pvt. Ltd
13.3.1 Overview
13.3.2 Financial Performance
13.3.3 Product Outlook
13.3.4 Key Developments
13.4 Merck Millipore
13.4.1 Overview
13.4.2 Financial Performance
13.4.3 Product Outlook
13.4.4 Key Developments
13.5 Cell Bio Labs, Inc.
13.5.1 Overview
13.5.2 Financial Performance
13.5.3 Product Outlook
13.5.4 Key Developments
13.6 Hemogenix Inc.
13.6.1 Overview
13.6.2 Financial Performance
13.6.3 Product Outlook
13.6.4 Key Developments
13.7 Stem Cell Technologies
13.7.1 Overview
13.7.2 Financial Performance
13.7.3 Product Outlook
13.7.4 Key Developments
13.8 Bio Rad
13.8.1 Overview
13.8.2 Financial Performance
13.8.3 Product Outlook
13.8.4 Key Developments
13.9 R&D Systems
13.9.1 Overview
13.9.2 Financial Performance
13.9.3 Product Outlook
13.9.4 Key Development
13.10 Cellular Dynamics International.
13.10.1 Overview
13.10.2 Financial Performance
13.10.3 Product Outlook
13.10.4 Key Development
14 Appendix
14.1 Related Reports
The CRISPR Cell Line Development Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Gene Knockdown Stable Cell Line Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Cell Line Customization Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cell Line Adaptation Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Battery Cell Authentication Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The School STEM Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
The STEM Learning Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...
The Stem Cell Biomanufacturing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The CD19-targeted CAR-T Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Osteoarthritis Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...